Click for best price
Lung Cancer Biomarkers Market Size, Share 2022
This report contains market size and forecasts of Lung Cancer Biomarkers in global, including the following market information:
Global Lung Cancer Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lung Cancer Biomarkers Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Lung Cancer Biomarkers companies in 2021 (%)
The global Lung Cancer Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Protein Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Biomarkers include Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomerieux SA, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Type, 2021 (%)
Protein Biomarker
Genetic Biomarker
Global Lung Cancer Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Research
Others
Global Lung Cancer Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Biomarkers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lung Cancer Biomarkers revenues share in global market, 2021 (%)
Key companies Lung Cancer Biomarkers sales in global market, 2017-2022 (Estimated), (Units)
Key companies Lung Cancer Biomarkers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Biomarkers Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Biomarkers Overall Market Size
2.1 Global Lung Cancer Biomarkers Market Size: 2021 VS 2028
2.2 Global Lung Cancer Biomarkers Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lung Cancer Biomarkers Sales: 2017-2028
3 Company Landscape
3.1 Top Lung Cancer Biomarkers Players in Global Market
3.2 Top Global Lung Cancer Biomarkers Companies Ranked by Revenue
3.3 Global Lung Cancer Biomarkers Revenue by Companies
3.4 Global Lung Cancer Biomarkers Sales by Companies
3.5 Global Lung Cancer Biomarkers Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lung Cancer Biomarkers Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lung Cancer Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Cancer Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Lung Cancer Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Lung Cancer Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Biomarkers Market Size Markets, 2021 & 2028
4.1.2 Protein Biomarker
4.1.3 Genetic Biomarker
4.2 By Type - Global Lung Cancer Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Biomarkers Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Biomarkers Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
4.3 By Type - Global Lung Cancer Biomarkers Sales & Forecasts
4.3.1 By Type - Global Lung Cancer Biomarkers Sales, 2017-2022
4.3.2 By Type - Global Lung Cancer Biomarkers Sales, 2023-2028
4.3.3 By Type - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
4.4 By Type - Global Lung Cancer Biomarkers Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Biomarkers Market Size, 2021 & 2028
5.1.2 Diagnostics
5.1.3 Research
5.1.4 Others
5.2 By Application - Global Lung Cancer Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Biomarkers Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Biomarkers Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
5.3 By Application - Global Lung Cancer Biomarkers Sales & Forecasts
5.3.1 By Application - Global Lung Cancer Biomarkers Sales, 2017-2022
5.3.2 By Application - Global Lung Cancer Biomarkers Sales, 2023-2028
5.3.3 By Application - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
5.4 By Application - Global Lung Cancer Biomarkers Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Biomarkers Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Biomarkers Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Biomarkers Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
6.3 By Region - Global Lung Cancer Biomarkers Sales & Forecasts
6.3.1 By Region - Global Lung Cancer Biomarkers Sales, 2017-2022
6.3.2 By Region - Global Lung Cancer Biomarkers Sales, 2023-2028
6.3.3 By Region - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Lung Cancer Biomarkers Revenue, 2017-2028
6.4.2 By Country - North America Lung Cancer Biomarkers Sales, 2017-2028
6.4.3 US Lung Cancer Biomarkers Market Size, 2017-2028
6.4.4 Canada Lung Cancer Biomarkers Market Size, 2017-2028
6.4.5 Mexico Lung Cancer Biomarkers Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Lung Cancer Biomarkers Revenue, 2017-2028
6.5.2 By Country - Europe Lung Cancer Biomarkers Sales, 2017-2028
6.5.3 Germany Lung Cancer Biomarkers Market Size, 2017-2028
6.5.4 France Lung Cancer Biomarkers Market Size, 2017-2028
6.5.5 U.K. Lung Cancer Biomarkers Market Size, 2017-2028
6.5.6 Italy Lung Cancer Biomarkers Market Size, 2017-2028
6.5.7 Russia Lung Cancer Biomarkers Market Size, 2017-2028
6.5.8 Nordic Countries Lung Cancer Biomarkers Market Size, 2017-2028
6.5.9 Benelux Lung Cancer Biomarkers Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Lung Cancer Biomarkers Revenue, 2017-2028
6.6.2 By Region - Asia Lung Cancer Biomarkers Sales, 2017-2028
6.6.3 China Lung Cancer Biomarkers Market Size, 2017-2028
6.6.4 Japan Lung Cancer Biomarkers Market Size, 2017-2028
6.6.5 South Korea Lung Cancer Biomarkers Market Size, 2017-2028
6.6.6 Southeast Asia Lung Cancer Biomarkers Market Size, 2017-2028
6.6.7 India Lung Cancer Biomarkers Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Lung Cancer Biomarkers Revenue, 2017-2028
6.7.2 By Country - South America Lung Cancer Biomarkers Sales, 2017-2028
6.7.3 Brazil Lung Cancer Biomarkers Market Size, 2017-2028
6.7.4 Argentina Lung Cancer Biomarkers Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Lung Cancer Biomarkers Sales, 2017-2028
6.8.3 Turkey Lung Cancer Biomarkers Market Size, 2017-2028
6.8.4 Israel Lung Cancer Biomarkers Market Size, 2017-2028
6.8.5 Saudi Arabia Lung Cancer Biomarkers Market Size, 2017-2028
6.8.6 UAE Lung Cancer Biomarkers Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bio-Rad Laboratories
7.1.1 Bio-Rad Laboratories Corporate Summary
7.1.2 Bio-Rad Laboratories Business Overview
7.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Major Product Offerings
7.1.4 Bio-Rad Laboratories Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.1.5 Bio-Rad Laboratories Key News
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Corporate Summary
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Lung Cancer Biomarkers Major Product Offerings
7.2.4 Roche Diagnostics Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.2.5 Roche Diagnostics Key News
7.3 Qiagen
7.3.1 Qiagen Corporate Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Biomarkers Major Product Offerings
7.3.4 Qiagen Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.3.5 Qiagen Key News
7.4 Illumina
7.4.1 Illumina Corporate Summary
7.4.2 Illumina Business Overview
7.4.3 Illumina Lung Cancer Biomarkers Major Product Offerings
7.4.4 Illumina Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.4.5 Illumina Key News
7.5 GE Healthcare
7.5.1 GE Healthcare Corporate Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Lung Cancer Biomarkers Major Product Offerings
7.5.4 GE Healthcare Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.5.5 GE Healthcare Key News
7.6 Agilent Technologies
7.6.1 Agilent Technologies Corporate Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Lung Cancer Biomarkers Major Product Offerings
7.6.4 Agilent Technologies Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.6.5 Agilent Technologies Key News
7.7 Biomerieux SA
7.7.1 Biomerieux SA Corporate Summary
7.7.2 Biomerieux SA Business Overview
7.7.3 Biomerieux SA Lung Cancer Biomarkers Major Product Offerings
7.7.4 Biomerieux SA Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.7.5 Biomerieux SA Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Lung Cancer Biomarkers Major Product Offerings
7.8.4 Merck Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Lung Cancer Biomarkers Major Product Offerings
7.9.4 Abbott Laboratories Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.9.5 Abbott Laboratories Key News
7.10 Becton, Dickinson and Company
7.10.1 Becton, Dickinson and Company Corporate Summary
7.10.2 Becton, Dickinson and Company Business Overview
7.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Major Product Offerings
7.10.4 Becton, Dickinson and Company Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.10.5 Becton, Dickinson and Company Key News
7.11 Danaher Corporation
7.11.1 Danaher Corporation Corporate Summary
7.11.2 Danaher Corporation Lung Cancer Biomarkers Business Overview
7.11.3 Danaher Corporation Lung Cancer Biomarkers Major Product Offerings
7.11.4 Danaher Corporation Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.11.5 Danaher Corporation Key News
7.12 Myriad Genetics
7.12.1 Myriad Genetics Corporate Summary
7.12.2 Myriad Genetics Lung Cancer Biomarkers Business Overview
7.12.3 Myriad Genetics Lung Cancer Biomarkers Major Product Offerings
7.12.4 Myriad Genetics Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.12.5 Myriad Genetics Key News
7.13 Sysmex Corporation
7.13.1 Sysmex Corporation Corporate Summary
7.13.2 Sysmex Corporation Lung Cancer Biomarkers Business Overview
7.13.3 Sysmex Corporation Lung Cancer Biomarkers Major Product Offerings
7.13.4 Sysmex Corporation Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.13.5 Sysmex Corporation Key News
7.14 Hologic
7.14.1 Hologic Corporate Summary
7.14.2 Hologic Business Overview
7.14.3 Hologic Lung Cancer Biomarkers Major Product Offerings
7.14.4 Hologic Lung Cancer Biomarkers Sales and Revenue in Global (2017-2022)
7.14.5 Hologic Key News
8 Global Lung Cancer Biomarkers Production Capacity, Analysis
8.1 Global Lung Cancer Biomarkers Production Capacity, 2017-2028
8.2 Lung Cancer Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Cancer Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lung Cancer Biomarkers Supply Chain Analysis
10.1 Lung Cancer Biomarkers Industry Value Chain
10.2 Lung Cancer Biomarkers Upstream Market
10.3 Lung Cancer Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lung Cancer Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Lung Cancer Biomarkers in Global Market
Table 2. Top Lung Cancer Biomarkers Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Lung Cancer Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Lung Cancer Biomarkers Revenue Share by Companies, 2017-2022
Table 5. Global Lung Cancer Biomarkers Sales by Companies, (Units), 2017-2022
Table 6. Global Lung Cancer Biomarkers Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Lung Cancer Biomarkers Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Lung Cancer Biomarkers Product Type
Table 9. List of Global Tier 1 Lung Cancer Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Lung Cancer Biomarkers Sales (Units), 2017-2022
Table 15. By Type - Global Lung Cancer Biomarkers Sales (Units), 2023-2028
Table 16. By Application ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Lung Cancer Biomarkers Sales (Units), 2017-2022
Table 20. By Application - Global Lung Cancer Biomarkers Sales (Units), 2023-2028
Table 21. By Region ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Lung Cancer Biomarkers Sales (Units), 2017-2022
Table 25. By Region - Global Lung Cancer Biomarkers Sales (Units), 2023-2028
Table 26. By Country - North America Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Lung Cancer Biomarkers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Lung Cancer Biomarkers Sales, (Units), 2017-2022
Table 29. By Country - North America Lung Cancer Biomarkers Sales, (Units), 2023-2028
Table 30. By Country - Europe Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Lung Cancer Biomarkers Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Lung Cancer Biomarkers Sales, (Units), 2017-2022
Table 33. By Country - Europe Lung Cancer Biomarkers Sales, (Units), 2023-2028
Table 34. By Region - Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Lung Cancer Biomarkers Sales, (Units), 2017-2022
Table 37. By Region - Asia Lung Cancer Biomarkers Sales, (Units), 2023-2028
Table 38. By Country - South America Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Lung Cancer Biomarkers Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Lung Cancer Biomarkers Sales, (Units), 2017-2022
Table 41. By Country - South America Lung Cancer Biomarkers Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Lung Cancer Biomarkers Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Lung Cancer Biomarkers Sales, (Units), 2023-2028
Table 46. Bio-Rad Laboratories Corporate Summary
Table 47. Bio-Rad Laboratories Lung Cancer Biomarkers Product Offerings
Table 48. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Roche Diagnostics Corporate Summary
Table 50. Roche Diagnostics Lung Cancer Biomarkers Product Offerings
Table 51. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Qiagen Corporate Summary
Table 53. Qiagen Lung Cancer Biomarkers Product Offerings
Table 54. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Illumina Corporate Summary
Table 56. Illumina Lung Cancer Biomarkers Product Offerings
Table 57. Illumina Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GE Healthcare Corporate Summary
Table 59. GE Healthcare Lung Cancer Biomarkers Product Offerings
Table 60. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Agilent Technologies Corporate Summary
Table 62. Agilent Technologies Lung Cancer Biomarkers Product Offerings
Table 63. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Biomerieux SA Corporate Summary
Table 65. Biomerieux SA Lung Cancer Biomarkers Product Offerings
Table 66. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Lung Cancer Biomarkers Product Offerings
Table 69. Merck Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Abbott Laboratories Corporate Summary
Table 71. Abbott Laboratories Lung Cancer Biomarkers Product Offerings
Table 72. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Becton, Dickinson and Company Corporate Summary
Table 74. Becton, Dickinson and Company Lung Cancer Biomarkers Product Offerings
Table 75. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Danaher Corporation Corporate Summary
Table 77. Danaher Corporation Lung Cancer Biomarkers Product Offerings
Table 78. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Myriad Genetics Corporate Summary
Table 80. Myriad Genetics Lung Cancer Biomarkers Product Offerings
Table 81. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Sysmex Corporation Corporate Summary
Table 83. Sysmex Corporation Lung Cancer Biomarkers Product Offerings
Table 84. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Hologic Corporate Summary
Table 86. Hologic Lung Cancer Biomarkers Product Offerings
Table 87. Hologic Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Lung Cancer Biomarkers Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 89. Global Lung Cancer Biomarkers Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Lung Cancer Biomarkers Production by Region, 2017-2022 (Units)
Table 91. Global Lung Cancer Biomarkers Production by Region, 2023-2028 (Units)
Table 92. Lung Cancer Biomarkers Market Opportunities & Trends in Global Market
Table 93. Lung Cancer Biomarkers Market Drivers in Global Market
Table 94. Lung Cancer Biomarkers Market Restraints in Global Market
Table 95. Lung Cancer Biomarkers Raw Materials
Table 96. Lung Cancer Biomarkers Raw Materials Suppliers in Global Market
Table 97. Typical Lung Cancer Biomarkers Downstream
Table 98. Lung Cancer Biomarkers Downstream Clients in Global Market
Table 99. Lung Cancer Biomarkers Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lung Cancer Biomarkers Segment by Type
Figure 2. Lung Cancer Biomarkers Segment by Application
Figure 3. Global Lung Cancer Biomarkers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Biomarkers Revenue, 2017-2028 (US$, Mn)
Figure 7. Lung Cancer Biomarkers Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Cancer Biomarkers Revenue in 2021
Figure 9. By Type - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 10. By Type - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 11. By Type - Global Lung Cancer Biomarkers Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 13. By Application - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 14. By Application - Global Lung Cancer Biomarkers Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 16. By Region - Global Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 17. By Country - North America Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 18. By Country - North America Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 19. US Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 24. Germany Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 25. France Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 33. China Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 37. India Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 39. By Country - South America Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 40. Brazil Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Lung Cancer Biomarkers Sales Market Share, 2017-2028
Figure 44. Turkey Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Lung Cancer Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 48. Global Lung Cancer Biomarkers Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Lung Cancer Biomarkers by Region, 2021 VS 2028
Figure 50. Lung Cancer Biomarkers Industry Value Chain
Figure 51. Marketing Channels
